Parental knowledge on the respiratory syncytial virus before the nirsevimab immunization program: Attitudes toward immunization in an autonomous community of Spain

• Ngā kaituhi matua: Matilde Zornoza Moreno (Author), Jaime Jesús Pérez Martín (Author), Mª Cruz Gómez Moreno (Author), Mª Pilar Ros Abellán (Author)
• Hōputu: Pukapuka
• I whakaputaina: Taylor & Francis Group, 2024-12-01T00:00:00Z.
• Ngā marau: article
• Urunga tuihono: Connect to this object online.

Respiratory syncytial virus (RSV) is the leading cause of lower respiratory tract infections in young children and associated with most bronchiolitis- and pneumonia-related hospitalizations. A new preventive monoclonal antibody (MAb), nirsevimab, has been launched in the United States, Luxembourg, a...